"Prognosis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations.
| Descriptor ID |
D011379
|
| MeSH Number(s) |
E01.789
|
| Concept/Terms |
Prognostic Factors- Prognostic Factors
- Factor, Prognostic
- Factors, Prognostic
- Prognostic Factor
|
Below are MeSH descriptors whose meaning is more general than "Prognosis".
- Analytical, Diagnostic and Therapeutic Techniques and Equipment [E]
- Diagnosis [E01]
- Prognosis [E01.789]
Below are MeSH descriptors whose meaning is more specific than "Prognosis".
This graph shows the total number of publications written about "Prognosis" by people in this website by year, and whether "Prognosis" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 23 | 23 |
| 1996 | 0 | 22 | 22 |
| 1997 | 0 | 29 | 29 |
| 1998 | 0 | 35 | 35 |
| 1999 | 0 | 29 | 29 |
| 2000 | 0 | 47 | 47 |
| 2001 | 0 | 38 | 38 |
| 2002 | 0 | 38 | 38 |
| 2003 | 0 | 57 | 57 |
| 2004 | 0 | 58 | 58 |
| 2005 | 0 | 62 | 62 |
| 2006 | 0 | 78 | 78 |
| 2007 | 0 | 89 | 89 |
| 2008 | 0 | 90 | 90 |
| 2009 | 0 | 101 | 101 |
| 2010 | 0 | 110 | 110 |
| 2011 | 0 | 140 | 140 |
| 2012 | 0 | 116 | 116 |
| 2013 | 2 | 159 | 161 |
| 2014 | 2 | 183 | 185 |
| 2015 | 0 | 183 | 183 |
| 2016 | 6 | 165 | 171 |
| 2017 | 3 | 209 | 212 |
| 2018 | 1 | 241 | 242 |
| 2019 | 1 | 258 | 259 |
| 2020 | 0 | 232 | 232 |
| 2021 | 1 | 152 | 153 |
| 2022 | 0 | 77 | 77 |
| 2023 | 0 | 98 | 98 |
| 2024 | 0 | 149 | 149 |
| 2025 | 0 | 89 | 89 |
To return to the timeline,
click here.
Below are the most recent publications written about "Prognosis" by people in Profiles.
-
Blood biomarkers for predicting disability worsening in progressive multiple sclerosis: a multinational, individual participant-level analysis. J Neurol Neurosurg Psychiatry. 2025 Oct 15; 96(11):1046-1052.
-
Advances and updates in pediatric anaplastic large cell lymphoma. Blood Adv. 2025 Oct 14; 9(19):4870-4880.
-
Carbonic Anhydrase Inhibition Sensitizes Group 3 Medulloblastoma to Radiotherapy. Cancer Res. 2025 Oct 01; 85(19):3737-3751.
-
Functional outcomes in pediatric patients on renal replacement therapy in a worldwide registry. Nephrol Dial Transplant. 2025 Sep 29; 40(10):1919-1930.
-
Visit-to-visit lipid variability, coronary artery calcification, inflammation, and mortality in the Multi-Ethnic Study of Atherosclerosis. Eur J Prev Cardiol. 2025 Sep 22; 32(13):1235-1244.
-
Feasibility of Atezolizumab in Combination With Chemotherapy for Children With Relapsed or Refractory Solid Tumors. Pediatr Blood Cancer. 2025 Dec; 72(12):e32046.
-
Single site metastatic rhabdomyosarcoma: An INternational Soft Tissue saRcoma ConsorTium (INSTRuCT) pooled analysis. Eur J Cancer. 2025 Oct 16; 229:115793.
-
Co-occurrence of congenital anomalies and childhood brain tumors in 22 million live births. Neuro Oncol. 2025 Sep 08; 27(7):1910-1922.
-
The effect of TERT promoter mutation on predicting meningioma outcomes: a multi-institutional cohort analysis. Lancet Oncol. 2025 Sep; 26(9):1178-1190.
-
Relation of left ventricular diastolic function to LV structure and outcomes in patients with aortic regurgitation. Eur Heart J Cardiovasc Imaging. 2025 Aug 29; 26(9):1560-1569.